Arnasi Group, Formerly LiquiGlide, Unveils Transformation into a Commercial Brand Company with New Management and Direction
Beyond the immense potential of LiquiGlide® technology, Salain believes that thoughtful internal brand development will help Arnasi™ address unmet patient and consumer needs through elevated product experiences.
- Beyond the immense potential of LiquiGlide® technology, Salain believes that thoughtful internal brand development will help Arnasi™ address unmet patient and consumer needs through elevated product experiences.
- He is accompanied by Dr. Noah Wolfson, VP of program management, and Dr. Brienne Engel, director of business development.
- Wolfson has developed brand strategies for more than eight pre-commercial and commercial products, while Engel has facilitated hundreds of collaborations between academic, biotech, and pharmaceutical partners.
- “We have such broad experience across categories, informing our focus on biomedical and CPG brand launches.”